Moreover, epigallocatechin gallate (EGCG) plays a potential adjunctive role in the prevention and management of diabetes, where it exerts antihyperglycemic effects by improving insulin sensitivity, reducing fasting blood glucose and modestly lowering HbA1c and HOMA-IR, shown by meta-analyses of randomized controlled trials. This evidence concerns the gene INS and diabetes mellitus.